No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeEXECUTIVES

Category: EXECUTIVES

Avation Medical adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO, Dennis D. Kim, MD, MBA Plus Secures Funding

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

Sanjay D Goorachurn New CEO at Medisca

Sanjay D Goorachurn is regarded as one of the world’s leading IP strategists working closely with senior executives of private and public companies on maximizing the commercial value of a company’s innovation and IP assets.

Frank Vizesi Appointed Chief Scientific Officer at Theradaptive | Strengthens Executive Team

Frank Vizesi brings over 20 years experience in cutting-edge orthobiologics research, with previous roles at NuVasive, SeaSpine and most recently as Chief Scientific Officer at Orthofix.

Cal Bontemps Appointed Radians Director of Marketing

Cal Bontemps brings a wealth of expertise to lead the marketing team while driving strategic alignment with Radians' sales goals and objectives.

CPR-Therapeutics Announces Mike Black as Chief Strategy Officer

Mike Black said, “I’m looking forward to advising the CPR Therapeutics team on the development of this important suite of medical technologies. I have a long-term commitment to improving the outcome of patients suffering cardiac arrest. CPR-T’s approach is a major opportunity to advance care and have a meaningful impact on one of the leading killers worldwide.”

Corinne Le Goff Appointed Viatris Chief Commercial Officer

Corinne Le Goff is an accomplished biotechnology and pharmaceutical executive with more than 25 years of experience leading and building highly successful teams globally.

Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

Julie Blasingim, formerly President, has over 20 years of experience in the clinical research industry.

By using this website you agree to accept Medical Device News Magazine Privacy Policy